Narsoplimab Wins Thrombotic Microangiopathy Approval
FDA Approves Narsoplimab for HSCT-Associated Thrombotic Microangiopathy
| Read More |
Minority/Medicaid Status Associated With Lower PRO Utilization in Oncology
| Read More |
Videos
|
‘Seamlessly’ Integrating Bioimpedance Spectroscopy Into Clinical Workflows
|
Durvalumab/FLOT Cemented as New SOC in Gastric/GEJ Cancers
|
Trending
|
What’s New in Hematology/Oncology? Discussing the 2025 ASH Annual Meeting
|
Human Coaching Via Mobile App May Reduce Postgastrectomy Symptoms
|
|
|||||||||||
|
